Evidence map›Paper›PMID 26873100›Full record

ArticleMetabolic brain disease2016

Elevated levels of serum cholesterol are associated with better performance on tasks of episodic memory.

Elizabeth C Leritz, Regina E McGlinchey, David H Salat, William P Milberg

Open access · greenAbstract read
In one paragraph

Article in Metabolic brain disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Metabolic Syndrome and Cognitive Function in Midlife.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Elizabeth C LeritzGeriatric Research, Education and Clinical Center (GRECC), VA Boston Healthcare System, Boston, MA, USA. elizabeth_leritz@hms.harvard.edu.
Regina E McGlincheyGeriatric Research, Education and Clinical Center (GRECC), VA Boston Healthcare System, Boston, MA, USA.
David H SalatGeriatric Research, Education and Clinical Center (GRECC), VA Boston Healthcare System, Boston, MA, USA.
William P MilbergGeriatric Research, Education and Clinical Center (GRECC), VA Boston Healthcare System, Boston, MA, USA.
VA Boston Healthcare System · USHarvard University · US

Funding

Cerebrovascular Contributions to Brain Aging and DementiaR01NR010827 · NINR · MASSACHUSETTS GENERAL HOSPITAL · PI SALAT, DAVID H · 2007 to 2017
$5.0M
Neuroimaging and Neuropsychological Biomarkers of Vascular Risk FactorsR01NS086882 · NINDS · HARVARD MEDICAL SCHOOL · PI LERITZ, ELIZABETH C · 2014 to 2018
$1.7M
The Impact of Risk for AD and CVD on Brain Structure and CognitionK23NS062148 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI LERITZ, ELIZABETH C · 2008 to 2012
$953k
NINDS NIH HHS K23 NS062148NINDS NIH HHS K23NS062148NINDS NIH HHS R01 NS086882NINDS NIH HHS R01NS086882NINR NIH HHS R01 NR010827NINR NIH HHS R01NR010827
6 · The paper itself

Abstract

We examined how serum cholesterol, an established risk factor for cerebrovascular disease (CVD), relates to cognitive function in healthy middle-older aged individuals with no neurologic or CVD history. A complete lipid panel was obtained from a cohort of one hundred twenty individuals, ages 43-85, who also underwent a comprehensive neuropsychological examination. In order to reduce the number of variables and empirically identify broad cognitive domains, scores from neuropsychological tests were submitted into a factor analysis. This analysis revealed three explainable factors: Memory, Executive Function and Memory/Language. Three separate hierarchical multiple regression analyses were conducted using individual cholesterol metrics (total cholesterol, low density lipoprotein; LDL, high density lipoprotein; HDL, and triglycerides), as well as age, education, medication status (lipid lowering agents), ApoE status, and additional risk factors for CVD to predict neuropsychological function. The Memory Factor was predicted by a combination of age, LDL, and triglyceride levels; both age and triglycerides were negatively associated with factor score, while LDL levels revealed a positive relationship. Both the Executive and Memory/Language factor were only explained by education, whereby more years were associated with better performance. These results provide evidence that individual cholesterol lipoproteins and triglycerides may differentially impact cognitive function, over and above other common CVD risk factors and ApoE status. Our findings demonstrate the importance of consideration of vascular risk factors, such as cholesterol, in studies of cognitive aging.

Indexed as

Memory, EpisodicAdultAgedAged, 80 and overCholesterolCognitionFemaleHumansMaleMiddle AgedNeuropsychological TestsRisk FactorsTriglyceridesCholesterolTriglyceridesCerebrovascular healthCerebrovascular riskCholesterolCognition

Identifiers

PMID26873100
PMCPMC4913474
OpenAlexW2262270609

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.